Evidence map›Paper›PMID 33151564›Full record

ArticleTransfusion2021

Autoantigen presentation by splenic dendritic cells is required for RBC-specific autoimmunity.

Amanda L Richards, Annie Qiu, Flavia Dei Zotti, Kathryn Sheldon, Chomkan Usaneerungrueng, David R Gruber, Krystalyn E Hudson

Open access · greenAbstract read
In one paragraph

Article in Transfusion, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. The Immunology of Transfusion Medicine: Past, Present, and Future.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  3. Article
  4. Article
  5. FcFrontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Amanda L RichardsBloodworks NW Research Institute, Seattle, Washington, USA.
Annie QiuDepartment of Pathology and Cell Biology, Columbia University, Irving Medical Center, New York, New York, USA.
Flavia Dei ZottiDepartment of Pathology and Cell Biology, Columbia University, Irving Medical Center, New York, New York, USA.
Kathryn SheldonBloodworks NW Research Institute, Seattle, Washington, USA.
Chomkan UsaneerungruengBloodworks NW Research Institute, Seattle, Washington, USA.
David R GruberBloodworks NW Research Institute, Seattle, Washington, USA.
Krystalyn E HudsonDepartment of Pathology and Cell Biology, Columbia University, Irving Medical Center, New York, New York, USA.ORCID 0000-0001-5663-9290
Bloodworks Northwest · USColumbia University Irving Medical Center · US

Funding

Immune Response to RBC AntigensR01HL133325 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Krystalyn E Hudson · 2017 to 2026
$4.5M
BD Biosciences InfluxS10OD020056 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SNOECK, HANS-WILLEM E · 2015 to 2015
$600k
National Blood FoundationNHLBI NIH HHS R01 HL133325NHLBI NIH HHS R01HL133325NIH HHS S10 OD020056
6 · The paper itself

Abstract

backgroundFailure of humoral tolerance to red blood cell (RBC) antigens may lead to autoimmune hemolytic anemia (AIHA), a severe and sometimes fatal disease. Previous studies have shown that although tolerance is robust in HOD mice, autoantibodies are generated upon adoptive transfer of OTII CD4 STUDY DESIGN AND

methodsHOD mice, which express an RBC-specific antigen consisting of hen egg lysozyme, ovalbumin, and human blood group molecule Duffy, were bred with IAb

resultsAnalysis of HOD

conclusionThese data suggest that if erythrocyte T-cell tolerance fails, DCs are capable of initiating autoimmune responses. As such, targeting DCs may be a fruitful strategy for AIHA therapies.

Indexed as

Anemia, Hemolytic, AutoimmuneAnimalsAutoantibodiesAutoantigensAutoimmunityCD4-Positive T-LymphocytesDendritic CellsErythrocytesFemaleHomeodomain ProteinsHumansImmune ToleranceLymphocyte ActivationMaleMiceMice, Inbred C57BLAutoantibodiesAutoantigensHod protein, mouseHomeodomain Proteinsautoimmune hemolytic anemiaautoimmunitydendritic cellerythrocytered blood cellstolerance

Identifiers

PMID33151564
PMCPMC9092285
OpenAlexW3095231198

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.